- 3670-68-61-Propanone,3-(1-piperidinyl)-1-(4-propoxyphenyl)-
- 36709-10-1CH3COO2
- 3671-08-72-Naphthacenecarboxamide,7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride, [4S-(4a,4aa,5aa,6b,12aa)]- (9CI)
- 367-11-31,2-Difluorobenzene
- 36711-31-61-Propanol,2,3-dibromo-, 1,1'-(hydrogen phosphate), magnesium salt (2:1)
- 36711-56-5Benzoicacid, 4-[(4-aminobenzoyl)amino]-
- 367-12-42-Fluorophenol
- 36713-33-4Ethanone,2-(dimethylamino)-1,2-diphenyl-
- 3671-39-4S-Ropivacaine Mesilate
- 36715-97-61,2-Benzenedicarbonitrile,3-methyl-
Hot Products
- 191-07-1Coronene
- 515-69-53-Cyclohexene-1-methanol,a,4-dimethyl-a-(4-methyl-3-penten-1-yl)-, (aR,1R)-rel-
- 930-21-22-Azetidinone
- 99-97-8N,N,4-Trimethylaniline
- 367-51-1Acetic acid,2-mercapto-, sodium salt (1:1)
- 3006-93-7N,N'-1,3-Phenylene bismaleimide
- 78-26-21,3-Propanediol,2-methyl-2-propyl-
- 154323-57-6Almotriptan
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Isoprinosine |
EINECS | 253-162-1 |
| CAS No. | 36703-88-5 | Density | N/A |
| PSA | 403.10000 | LogP | 1.76610 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C10H12N4O5.3(C9H9NO3).3(C5H13NO) | Boiling Point | 732.8 °C at 760 mmHg |
| Molecular Weight | 1115.23 | Flash Point | 397 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
4-acetamidobenzoic acid; 9-[(2R,3R,4R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; 1-dimethylaminopropan-2-ol;IPS;Delimmun;Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3);Viruxan;NPT 10381;INPX;Aviral;Isoprinosina;Inosine, compound with (2-hydroxypropyl)dimethylammonium p-acetamidobenzoate (1:3);Inosine,compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3);Inosine pranobex [BAN:JAN];Inosine, mono[4-(acetylamino)benzoate] (salt), compd with 1- (Dimethylamino)-2-propanol (1:3);Methisoprinol;Inosine pranobex (JAN);Inosine pranobex;NTP 10381;Isoprinosin;p-Acetamidobenzoic salt of N,N-dimethylamino-2-propanol & inosine (3:1);Inosine & 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3);NP 113;4-acetamidobenzoic acid; 9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; 1-dimethylaminopropan-2-ol;Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3);Isoviral;Isoprinosine (TN);Inosiplex;Immunovir;Imunovir; |
Isoprinosine Specification
The Isoprinosine is an organic compound with the formula C10H12N4O5.3(C9H9NO3).3(C5H13NO). The IUPAC name of this chemical is 4-acetamidobenzoic acid; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; 1-(dimethylamino)propan-2-ol. With the CAS registry number 36703-88-5, it is also named as Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3). The product's classification codes are Adjuvants, immunologic; Anti-Infective Agents; Antiretroviral; Antiviral; Antiviral agents; Immunologic Factors; Immunomodulator; Immunostimulant. Besides, it is used as an antiviral drug. It acts as a powerful immunostimulant. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy, with promising results.
Physical properties about Isoprinosine are: (1)ACD/LogP: -2.32; (2)ACD/LogD (pH 5.5): -2.32; (3)ACD/LogD (pH 7.4): -2.32; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1.29; (7)ACD/KOC (pH 7.4): 1.3; (8)#H bond acceptors: 9; (9)#H bond donors: 4; (10)#Freely Rotating Bonds: 5; (11)Polar Surface Area: 87.41 Å2; (12)Flash Point: 397 °C; (13)Enthalpy of Vaporization: 112.25 kJ/mol; (14)Boiling Point: 732.8 °C at 760 mmHg; (15)Vapour Pressure: 1.52E-22 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(O)c1ccc(NC(=O)C)cc1.O=C(O)c1ccc(NC(=O)C)cc1.O=C(O)c1ccc(NC(=O)C)cc1.O=C3/N=C\Nc1c3ncn1[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO.OC(C)CN(C)C.OC(C)CN(C)C.OC(C)CN(C)C
(2)InChI: InChI=1/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1
(3)InChIKey: YLDCUKJMEKGGFI-QCSRICIXBM
(4)Std.InChI: InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1
(5)Std. InChIKey: YLDCUKJMEKGGFI-QCSRICIXSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 2300mg/kg (2300mg/kg) | Drugs in Japan Vol. -, Pg. 124, 1990. | |
| mouse | LD50 | intravenous | 1570mg/kg (1570mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. | |
| mouse | LD50 | oral | 9410mg/kg (9410mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. | |
| mouse | LD50 | subcutaneous | 2960mg/kg (2960mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. | |
| rat | LD50 | intraperitoneal | 2960mg/kg (2960mg/kg) | Drugs in Japan Vol. -, Pg. 124, 1990. | |
| rat | LD50 | intravenous | 1970mg/kg (1970mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. | |
| rat | LD50 | oral | 9150mg/kg (9150mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. | |
| rat | LD50 | subcutaneous | 3460mg/kg (3460mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 906, 1988. |
What can I do for you?
Get Best Price
